Morphogenic Compound-Releasing Microspheres for Long-Term Neural Bioink
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current pre-clinical models for tissue engineering, such as in vivo animal studies and cadaveric bodies, often fail to replicate the architecture and physiology of tissues like the brain and spinal cord, limiting their translation into clinical trials, and there is a need for compositions and methods that support long-lasting differentiation from stem cells.
Innovation Solution
A bioink comprising cells, biodegradable polymers, and microspheres that release morphogenic compounds, such as purmorphamine and guggulsterone, is used in three-dimensional bioprinting to create functional tissues, with methods involving bioprinting layers using an inkjet bioprinter and measuring markers of differentiation and maturation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pre-clinical models use in vivo animal studies and cadaveric bodies, then tissue engineering can be performed, but the architecture and physiology of tissues cannot be replicated
Solution Approach 1:
The patent segments the tissue engineering process into distinct functional components: stem cells as the cellular building blocks, bioink as the delivery medium, and microspheres as the morphogenic compound carriers. This segmentation allows each component to be optimized independently for its specific function while working together to replicate complex tissue architecture and physiology that cannot be achieved in traditional in vivo models.
Solution Approach 2:
The patent introduces microspheres as intermediary carriers that deliver morphogenic compounds to stem cells. These microspheres act as mediators between the external environment and the stem cells, providing controlled release of signaling molecules that guide differentiation and tissue formation, thereby enabling precise control over tissue architecture and physiology.
2Duration of action of moving object
If stem cell differentiation is supported with long-lasting characteristics, then functional tissues can be generated, but the differentiation process requires sustained morphogenic compound delivery
Solution Approach 1:
The microspheres are designed to be self-degrading, utilizing their own structural breakdown to release encapsulated morphogenic compounds over time. This self-service mechanism eliminates the need for external delivery systems or complex control mechanisms, allowing sustained compound release through the natural degradation process of the microsphere material itself.
Solution Approach 2:
The patent utilizes phase transitions in the microsphere material degradation process to control compound release. As the microsphere material degrades from a solid state through hydrolysis and enzymatic breakdown, the structural changes enable progressive release of morphogenic compounds, providing sustained signaling over extended periods without requiring additional energy input or complex mechanisms.
3Duration of action of stationary object
If microspheres release morphogenic compounds through polymer degradation, then sustained compound release is achieved, but the polymer must be biodegradable
Solution Approach 1:
The patent employs parameter changes in polymer selection, specifically adjusting molecular weight, crystallinity, and compositional ratios of biodegradable polymers to control degradation rates and compound release durations. By modifying these parameters, the system can accommodate various tissue engineering applications with different temporal requirements while maintaining the biodegradability constraint.
Solution Approach 2:
The patent utilizes composite material structures combining biodegradable polymers with morphogenic compounds within microsphere matrices. These composite microspheres integrate the structural integrity needed for sustained delivery with the biodegradability required for controlled release, achieving both long-duration compound release and biological compatibility through material composition rather than single-material properties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The bioink and bioprinting methods facilitate the development of functional neural tissues that mimic natural tissues, as evidenced by increased expression of markers like ChAT, O4, NeuN, and decreased expression of pluripotent markers, supporting the creation of viable neural tissues for drug screening and disease modeling.
Implementation Method 1
the microspheres include one or more biodegradable polymers and one or more compounds (such as drugs or small molecules). In some examples, the one or more compounds release with degradation of the one or more biodegradable polymers.
Data Source
AI summary
The bioink disclosed herein includes one or more cells, a carrier material, and microspheres. The microspheres can include one or more biodegradable polymers and one or more compounds, such as a morphogenic compound. The methods disclosed herein can include three-dimensional bioprinting. Additional methods disclosed herein include producing functional tissue.